Cargando…
Differential malondialdehyde (MDA) detection in plasma samples of patients with major depressive disorder (MDD): A potential biomarker
OBJECTIVE: To measure plasma levels of malondialdehyde (MDA), a marker of oxidative stress (OS), in patients with major depressive disorder (MDD) compared with healthy control (HC) subjects in order to determine if it is a possible biomarker of depression. METHODS: This prospective cross-sectional s...
Autores principales: | Alvarez-Mon, Miguel A, Ortega, Miguel A, García-Montero, Cielo, Fraile-Martinez, Oscar, Lahera, Guillermo, Monserrat, Jorge, Gomez-Lahoz, Ana M, Molero, Patricio, Gutierrez-Rojas, Luis, Rodriguez-Jimenez, Roberto, Quintero, Javier, Alvarez-Mon, Melchor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149615/ https://www.ncbi.nlm.nih.gov/pubmed/35615790 http://dx.doi.org/10.1177/03000605221094995 |
Ejemplares similares
-
Exploring the Role of Nutraceuticals in Major Depressive Disorder (MDD): Rationale, State of the Art and Future Prospects
por: Alvarez-Mon, Miguel A., et al.
Publicado: (2021) -
Prognostic Value of Malondialdehyde (MDA) in the Temporal Progression of Chronic Spinal Cord Injury
por: Haro Girón, Sergio, et al.
Publicado: (2023) -
Immune-Mediated Diseases from the Point of View of Psychoneuroimmunoendocrinology
por: Ortega, Miguel A., et al.
Publicado: (2022) -
An Updated View of the Importance of Vesicular Trafficking and Transport and Their Role in Immune-Mediated Diseases: Potential Therapeutic Interventions
por: Ortega, Miguel A., et al.
Publicado: (2022) -
Microbiota–gut–brain axis mechanisms in the complex network of bipolar disorders: potential clinical implications and translational opportunities
por: Ortega, Miguel A., et al.
Publicado: (2023)